Home › Atherosclerosis › Nevada › Las Vegas
Atherosclerosis clinical trials in Las Vegas, NV
5 studies for Atherosclerosis are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RecruitingPhase 3
- Vector Clinical Trials, Las Vegas
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Excel Clinical Research, LLC, Las Vegas
- Palm Research Center Tenaya, Las Vegas
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Clinical Research of South Nevada, Las Vegas
- Vector Clinical Trials, Las Vegas
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Kidney Specialists of Southern Nevada, Las Vegas
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Las Vegas
- Research Site, Las Vegas
- Research Site, Las Vegas
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA9 studies
- Houston, TX7 studies
- Washington, DC7 studies
- Durham, NC6 studies
- Hialeah, FL6 studies
- San Diego, CA5 studies
- Santa Monica, CA5 studies
- Minneapolis, MN5 studies
- Omaha, NE5 studies
- Dallas, TX5 studies
- Memphis, TN5 studies
- Tucson, AZ5 studies
Other studies in Las Vegas
- Obesity21 studies
- Overweight19 studies
- Type 2 Diabetes17 studies
- Major Depressive Disorder13 studies
- Breast Cancer11 studies
- Non-Small Cell Lung Cancer10 studies
- Cancer (all types)9 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Schizophrenia7 studies
- Prostate Cancer7 studies
- Alzheimer's Disease7 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.